Central AT2 receptor stimulation improves stroke

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Stroke is Australia's second single greatest killer and a leading cause of disability, with high blood pressure associated with a greater risk of stroke occurring. We have evidence of a possible new target, the angiotensin type 2 receptor that is protective in stroke. This proposal involves elucidating the mechanisms underlying this protective effect which may lead to new therapeutic strategies in treating stroke.

Funded Activity Details

Start Date: 01-01-2011

End Date: 01-01-2013

Funding Scheme: NHMRC Project Grants

Funding Amount: $308,071.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cardiology (incl. Cardiovascular Diseases)

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

hypertension | ischaemia/reperfusion | ischaemic stroke | neuropharmacology | neuroprotection | pharmacological intervention | stroke | stroke prevention